TickerFacts.

Regeneron Pharmaceuticals, Inc. (REGN): Dividends Paid

Annual figures by period end, from SEC filings.

$370.30M
Year ended 2025-12-31
$378.50M
Trailing 12 months to 2026-06-30
2023-12-31: $02024-12-31: $02025-12-31: $370.30M$370.30M
2023-12-31 Dividends Paid (USD) 2025-12-31
Period endedDividends PaidChange YoYSource filing
2025-12-31$370.30Mn/a2026-02-04, From 2025-01-01
2024-12-31$0n/a2026-02-04, From 2024-01-01
2023-12-31$0n/a2026-02-04, From 2023-01-01

Dividends Paid at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDividends PaidChange YoY
Regeneron Pharmaceuticals, Inc. (REGN)2025-12-31$370.30Mn/a
Organon & Co. (OGN)2025-12-31$88.00M-70.4%
Abbott Laboratories (ABT)2025-12-31$4.12B+7.3%
Bristol Myers Squibb Co (BMY)2025-12-31$5.04B+3.7%
Perrigo Co PLC (PRGO)2025-12-31$159.30M+4.5%
AbbVie Inc. (ABBV)2025-12-31$11.66B+5.7%
Merck & Co., Inc. (MRK)2025-12-31$8.18B+4.3%
Eli Lilly & Co (LLY)2025-12-31$5.38B+15.0%
Phibro Animal Health Corp (PAHC)2026-06-30$19.46M+0.1%

Compare REGN, OGN, ABT, BMY side by side · Screen every company in Pharmaceutical Preparations ↗